Triple recognition of B-DNA by a neomycin-Hoechst 33258-pyrene conjugate.
Recent developments have indicated that aminoglycoside binding is not limited to RNA, but to nucleic acids that, like RNA, adopt conformations similar to its A-form. We further sought to expand the utility of aminoglycoside binding to B-DNA structures by conjugating neomycin, an aminoglycoside antibiotic, with the B-DNA minor groove binding ligand Hoechst 33258. Envisioning a dual groove binding mode, we have extended the potential recognition process to include a third, intercalative moiety. Similar conjugates, which vary in the number of binding moieties but maintain identical linkages to allow direct comparisons to be made, have also been prepared. We report herein novel neomycin- and Hoechst 33258-based conjugates developed in our laboratories for exploring the recognition potential with B-DNA. Spectroscopic studies such as UV melting, differential scanning calorimetry, isothermal fluorescence titrations, and circular dichroism together illustrate the triple recognition of the novel conjugate containing neomycin, Hoechst 33258, and pyrene. This study represents the first example of DNA molecular recognition capable of minor versus major groove recognition in conjunction with intercalation.
Willis
Bert
B
Laboratories of Medicinal Chemistry, Clemson University, Clemson, South Carolina 29634, USA.
Arya
Dev P
DP
D006690:Bisbenzimidazole / Q000737:chemistry*; D002942:Circular Dichroism; D004247:DNA / Q000737:chemistry*; D008024:Ligands; D009355:Neomycin / Q000737:chemistry*; D009690:Nucleic Acid Conformation; D011721:Pyrenes / Q000737:chemistry*; D013056:Spectrophotometry, Ultraviolet; D013379:Substrate Specificity
D008024:Ligands; D011721:Pyrenes; D004247:DNA; C030984:pyrene; D009355:Neomycin; D006690:Bisbenzimidazole